Market Overview

Pieris Pharmaceuticals, Inc. (PIRS)

2.07 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.07
13.261M



Q4 2020
Pre-Market
EPS:
REV:
-0.06
17.27M



Q3 2020
Pre-Market
EPS:
REV:
-0.05
15.132M



Q2 2020
Pre-Market
EPS:
REV:
-0.24
5.332M
-0.17
7.76M
-0.09
11.246M
47.06%
44.92%
Q1 2020
Pre-Market
EPS:
REV:
-0.20
8.545M
-0.17
8.84M
-0.07
13.261M
58.82%
50.01%
Q4 2019
Pre-Market
EPS:
REV:
-0.21
4.914M
-0.28
4.82M
-0.06
17.27M
78.57%
258.3%
Q3 2019
Pre-Market
EPS:
REV:
-0.11
8.345M
-0.23
6.42M
-0.05
15.132M
78.26%
135.7%
Q2 2019
Pre-Market
EPS:
REV:

11.691M
-0.20
8.2M
-0.24
5.332M
-20%
-34.98%
Q1 2019
Pre-Market
EPS:
REV:
-0.17
4.152M
-0.18
7.56M
-0.20
8.545M
-11.11%
13.03%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!